Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2012; 18(39): 5581-5588
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5581
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5581
Table 1 Clinicopathological factors of the gastric cancer patients
| Characteristics | Microarray(n = 65) | qRT-PCR(n = 68) | TMA(n = 328) |
| Age | |||
| mean (range), yr | 63 (32-83) | 56 (26-82) | 57 (25-82) |
| Sex, n (%) | |||
| Male/female | 46 (71)/19 (29) | 36 (53)/32 (47) | 204 (62)/124 (38) |
| Follow up duration | |||
| Mean (95% CI), mo | 41.7 (41-42) | 89.5 (79-100) | 99.8 (97.5-102) |
| Histological type, n (%) | |||
| Intestinal | 23 (35) | 14 (21) | 100 (30) |
| Diffuse | 42 (65) | 54 (79) | 228 (70) |
| TNM stage, n (%) | |||
| I | 12 (18) | 0 | 101 (31) |
| II | 11 (17) | 0 | 79 (24) |
| III | 26 (40) | 68 (100) | 110 (33) |
| IV | 16 (25) | 0 | 38 (12) |
| Location, n (%) | |||
| Cardia | 5 (8) | 8 (12) | 25 (8) |
| Non cardia | 60 (92) | 60 (88) | 303 (92) |
| Adjuvant chemotherapy, n (%) | |||
| Yes | 49 (75) | 59 (87) | 230 (70) |
| No | 16 (25) | 9 (13) | 98 (30) |
- Citation: Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. World J Gastroenterol 2012; 18(39): 5581-5588
- URL: https://www.wjgnet.com/1007-9327/full/v18/i39/5581.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i39.5581